Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Veldwijk et al. conducted a study to assess the importance of criteria describing methods for decision-makers in the medical product lifecycle (MPLC) and evaluate the suitability of various preference elicitation methods at each decision point. Using multicriteria decision analysis, an online survey was conducted among MPLC decision makers, who ranked and weighted 19 methods criteria. The results showed that criteria related to estimating trade-offs and weights for treatment characteristics were consistently important across all MPLC decision points. Additionally, swing weighting and probabilistic threshold techniques were found to be more suitable than other methods. The study highlights the need to consider other preference elicitation methods and suggests the development of evidence-based guidelines for their effective utilization.

Access the full-text article here.